How do you use Mavyret in a sentence? See 2 example sentences showing how this word appears in different contexts.
Mavyret in a sentence
Context around Mavyret
- Average sentence length in these examples: 29 words
- Position in the sentence: 1 start, 1 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Mavyret
- In this selection, "mavyret" usually appears near the start of the sentence. The average example has 29 words, and this corpus slice is mostly made up of statements.
- Around the word, drug stand out and add context to how "mavyret" is used.
- Recognizable usage signals include new drug mavyret which treats and such as mavyret and creon. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "mavyret" sits close to words such as aabc, aacr and aacsb, which helps place it inside the broader word index.
Example types with mavyret
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
That's despite competition from ) new drug Mavyret, which treats a wide group of hepatitis C patients. (17 words)
Other products such as Mavyret and Creon appear to have many more years of blockbuster sales ahead of them, although it is interesting to note that AbbVie no longer reports revenues from its Women's Health division, and scarcely mentions it. (41 words)
Other products such as Mavyret and Creon appear to have many more years of blockbuster sales ahead of them, although it is interesting to note that AbbVie no longer reports revenues from its Women's Health division, and scarcely mentions it. (41 words)
That's despite competition from ) new drug Mavyret, which treats a wide group of hepatitis C patients. (17 words)
Example sentences (2)
Other products such as Mavyret and Creon appear to have many more years of blockbuster sales ahead of them, although it is interesting to note that AbbVie no longer reports revenues from its Women's Health division, and scarcely mentions it.
That's despite competition from ) new drug Mavyret, which treats a wide group of hepatitis C patients.